What started as a small investigation between client projects, over the years, has grown into a project of great significance. Our team at Symeres CZ developed a new process for the production of Penfluridol, a powerful antipsychotic used in the treatment of schizophrenia. In the past months, process validation was completed, culminating in a successful inspection by the Czech authorities, SUKL. With completing this important step, the path is clear for our client to obtain market authorization and deliver our high-quality product to patients over the course of this year. This is a major achievement by our team in Prague and an important milestone for Symeres.
